Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws this summer, [...] …
Articles by : Shannon Young, Associate Editor/Senior Writer
Beacon Hill lawmakers are expected to vote Thursday on a proposal that would prohibit pharmacy benefit managers (PBMs) from imposing [...] …
The House panel responsible for federal appropriations legislation passed a bill last week that would cut funding for the Health [...] …
The rates 340B pediatric hospitals negotiate with payers for new pediatric oncology drugs often exceed a medication’s average sale price, [...] …
As hospital advocates prepared to begin their annual summer visits to Capitol Hill this week, five congressional Democrats signed on [...] …
Editor’s Note: In Tuesday’s issue, we looked at comments from 340B provider stakeholders, today we look more closely at the [...] …
A Canadian drug manufacturer recently announced that it will refund covered entities for hundreds of different products purchased between 2021 [...] …
Editor’s Note: In today’s issue, we look at the 340B provider community’s comments to CMS. In a future issue, we [...] …
A Japanese drug manufacturer has ended its 340B contract pharmacy restrictions in Maryland and Mississippi in conjunction with new contract [...] …
Two major drug manufacturers are suing Minnesota to block a new 340B contract pharmacy access law, which took effect this [...] …